Rocket Lab Completes at the Market Offering

Rocket Lab (Nasdaq: RKLB) completed its previously disclosed at-the-market equity offering program on April 8, 2026.

Rhea-AI Summary

Rocket Lab (Nasdaq: RKLB) completed its previously disclosed at-the-market equity offering program on April 8, 2026. The company sold 6,726,862 shares in at-the-market transactions for aggregate gross proceeds of approximately $474 million.

Rocket Lab also entered collared forward transactions covering 7,451,200 shares with minimum expected proceeds of about $474 million and maximum expected proceeds of about $642 million, with scheduled maturities in April 2028. The company intends to use net proceeds for growth, potential acquisitions, and general corporate and working capital purposes.

Positive

• Gross proceeds of approximately $474 million from at-the-market sales
• Entered collared forward transactions with minimum $474M and maximum $642M expected proceeds
• Filed prospectus supplement to offer up to $1,000,000,000 aggregate offering price

Negative

• Sale of 6,726,862 shares and 7,451,200 forward-covered shares may cause share dilution
• Actual proceeds from collared forwards uncertain due to cap/floor and settlement timing

Argus Apr 8 session

+4.16% close to close Open Argus

Details

News Market Reaction – RKLB

On Apr 8, the day this news came out, RKLB closed 4.16% above the previous close.

Data tracked by StockTitan Argus for the Apr 8 session.

Market Context

This announcement details completion of Rocket Lab’s ATM equity program, including sale of 6,726,862...

Analysis

This announcement details completion of Rocket Lab’s ATM equity program, including sale of 6,726,862 shares for approximately $474 million in gross proceeds and 7,451,200 shares via collared forwards with minimum and maximum expected proceeds between $474 million and $642 million through April 2028. In context of recent contract wins and acquisition approvals, investors may focus on how this added capital supports future launches, integration of Mynaric, and expansion of hypersonics and satellite programs, while accounting for increased share count.

Key Figures

ATM program size: $1,000,000,000 Shares sold ATM: 6,726,862 shares Gross proceeds ATM: approximately $474 million +5 more

ATM program size

$1,000,000,000

Aggregate offering price under prospectus supplement filed March 17, 2026

Shares sold ATM

6,726,862 shares

Shares sold in at-the-market transactions under ATM Program

Gross proceeds ATM

approximately $474 million

Aggregate gross proceeds before commissions and expenses from ATM sales

Collared forward shares

7,451,200 shares

Shares sold via collared forward transactions under ATM Program

Min forward proceeds

approximately $474 million

Minimum expected proceeds from collared forward transactions

Max forward proceeds

approximately $642 million

Maximum expected proceeds from collared forward transactions

Forward maturity timing

April 2028

Scheduled maturity dates for collared forward transactions

Current share price

$66.32

Price before news, about 33.4% below 52-week high

Historical Context

5 past events · Latest: Mar 30

5 events

1. Mar 30

   Acquisition approval

   24h Move

   +11.9%

   Regulatory approval for Mynaric acquisition supporting SDA contract and manufacturing scale-up.

2. Mar 20

   Launch success

   24h Move

   -6.5%

   Successful Synspective launch and extended partnership with 19 additional dedicated missions.

3. Mar 18

   Major contract win

   24h Move

   +3.5%

   $190M block-buy for 20 HASTE test flights, lifting launch and space systems backlog.

4. Mar 05

   Launch cadence update

   24h Move

   +0.2%

   83rd mission completion underscoring high small-launch cadence and integrated capabilities.

5. Feb 27

   Hypersonic launch

   24h Move

   +2.7%

   7th HASTE hypersonic test mission maintaining a 100% success record for the program.

24h Move is the share-price change in the day after each event; other market factors may also have contributed.

Key Terms

at-the-market, equity offering, prospectus supplement, collared forward transactions, +1 more

5 terms

at-the-market financial

"announced it has completed its previously disclosed “at-the-market” equity offering program"

"At-the-market" is a method for companies to sell new shares of stock directly into the open market over time, rather than all at once. It allows companies to raise money gradually, similar to selling slices of a pie instead of the entire pie at once, which can help manage the sale's impact on the stock price. This approach gives investors a steady supply of shares while providing companies with flexible funding options.

equity offering financial

"its previously disclosed “at-the-market” equity offering program (the “ATM Program”)."

An equity offering is when a company sells new shares to investors to raise money, similar to cutting a larger pizza into more slices to bring to a party. It matters because it changes ownership stakes — existing shareholders own a smaller portion of the company after the sale — and can affect the stock price and future profits depending on how the raised funds are used.

prospectus supplement regulatory

"filed a prospectus supplement with the U.S. Securities and Exchange Commission"

A prospectus supplement is an additional document provided alongside a company's main offering details, offering updated or extra information about a specific financial product being sold. It helps investors understand the latest terms, risks, and details of the investment, similar to how an update or revision clarifies or expands on original instructions, ensuring they have current and complete information before making a decision.

collared forward transactions financial

"the Company entered into collared forward transactions and sold an aggregate of 7,451,200 shares"

A collared forward transaction is a hedging deal that locks in the future exchange of an asset or cash flow within a capped range by combining a forward contract with a purchased floor (minimum price) and a sold cap (maximum price). For investors, it matters because it reduces downside risk like a safety net while preserving some upside potential, making future revenues or costs more predictable without fully giving up gains—think of selling an item with a guaranteed minimum and a capped sale price.

floor price financial

"as well as the cap price and floor price set forth in each collared forward transaction."

The floor price is the minimum price at which a security, asset, or offering will be sold or accepted, acting like a seller’s “bottom line” or a reserve in an auction. For investors it matters because it sets a visible downside limit and can influence trading, valuation, and expectations of risk—like knowing there’s a safety net that a sale won’t go below a set level.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

LONG BEACH, Calif., April 08, 2026 (GLOBE NEWSWIRE) -- Rocket Lab Corporation (Nasdaq: RKLB) (“Rocket Lab” or the “Company”), a global leader in launch services and space systems, today announced it has completed its previously disclosed “at-the-market” equity offering program (the “ATM Program”).

On March 17, 2026, Rocket Lab filed a prospectus supplement with the U.S. Securities and Exchange Commission to offer and sell shares of the Company’s common stock having an aggregate offering price of up to $1,000,000,000. The Company sold an aggregate of 6,726,862 shares under the ATM Program in at-the-market transactions for aggregate gross proceeds (before commissions and offering expenses) of approximately $474 million. Additionally, pursuant to the ATM Program, the Company entered into collared forward transactions and sold an aggregate of 7,451,200 shares of common stock for minimum expected proceeds of approximately $474 million and maximum expected proceeds of approximately $642 million. The minimum and maximum expected proceeds are based on maturity dates scheduled to occur in April 2028. Actual proceeds will depend on, among other things, if the Company elects to settle the collared forward transactions prior to the scheduled maturity dates, as well as the cap price and floor price set forth in each collared forward transaction.

Rocket Lab intends to use the net proceeds from the ATM Program to fund future growth, including potential future acquisitions, and for general corporate and working capital purposes.

Rocket Lab Investor Relations
investors@rocketlabusa.com

Forward Looking Statements

This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. We intend such forward-looking statements to be covered by the safe harbor provisions for forward looking statements contained in Section 27A of the Securities Act of 1933, as amended (the “Securities Act”) and Section 21E of the Securities Exchange Act of 1934, as amended (the “Exchange Act”). All statements contained in this press release other than statements of historical fact, including, without limitation, statements regarding our launch and space systems operations, launch schedule and window, safe and repeatable access to space, Neutron development, operational expansion and business strategy are forward-looking statements. The words “believe,” “may,” “will,” “estimate,” “potential,” “continue,” “anticipate,” “intend,” “expect,” “strategy,” “future,” “could,” “would,” “project,” “plan,” “target,” and similar expressions are intended to identify forward-looking statements, though not all forward-looking statements use these words or expressions. These statements are neither promises nor guarantees, but involve known and unknown risks, uncertainties and other important factors that may cause our actual results, performance or achievements to be materially different from any future results, performance or achievements expressed or implied by the forward-looking statements, including but not limited to the factors, risks and uncertainties included in our Annual Report on Form 10-K for the fiscal year ended December 31, 2025, as such factors may be updated from time to time in our other filings with the Securities and Exchange Commission (the “SEC”), accessible on the SEC’s website at www.sec.gov and the Investor Relations section of our website at www.rocketlabusa.com, which could cause our actual results to differ materially from those indicated by the forward-looking statements made in this press release. Any such forward-looking statements represent management’s estimates as of the date of this press release. While we may elect to update such forward-looking statements at some point in the future, we disclaim any obligation to do so, even if subsequent events cause our views to change.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What did Rocket Lab (RKLB) announce on April 8, 2026 about its ATM offering?

Rocket Lab completed its at-the-market offering, selling 6,726,862 shares for about $474 million. According to the company, it also entered collared forward transactions covering 7,451,200 shares with expected proceeds between $474 million and $642 million, maturing in April 2028.

How much cash did RKLB raise from the at-the-market transactions on April 8, 2026?

RKLB raised approximately $474 million in aggregate gross proceeds from at-the-market sales. According to the company, that figure is before commissions and offering expenses and excludes potential additional proceeds from collared forward transactions.

What are the terms of the collared forward transactions Rocket Lab entered under the ATM program?

The collared forwards cover 7,451,200 shares with minimum expected proceeds of about $474 million and maximum expected proceeds of about $642 million. According to the company, actual proceeds depend on cap/floor prices and potential early settlement before April 2028 maturity.

How will the proceeds from RKLB's ATM program be used by the company?

The company intends to use net proceeds to fund future growth, including potential acquisitions, and for general corporate and working capital purposes. According to the company, these uses are the stated priorities for the funds raised under the ATM program.

Did Rocket Lab set a maximum offering size for the ATM program filed March 17, 2026?

Yes; Rocket Lab filed a prospectus supplement to offer up to $1,000,000,000 aggregate offering price under the ATM program. According to the company, the prospectus supplement authorized offers and sales up to that aggregate amount.

When do the collared forward transactions entered by RKLB mature and affect proceeds?

The collared forward transactions have scheduled maturities in April 2028, which determine minimum and maximum expected proceeds. According to the company, actual settlement timing or early election to settle could change final proceeds.